These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2991708)
1. Mammographic breast cancer screening--a randomized trial in Malmö, Sweden. Andersson I; Janzon L; Sigfússon BF Maturitas; 1985 May; 7(1):21-9. PubMed ID: 2991708 [TBL] [Abstract][Full Text] [Related]
2. Mammography screening in the county of Fyn. November 1993-December 1999. Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252 [TBL] [Abstract][Full Text] [Related]
3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674 [TBL] [Abstract][Full Text] [Related]
4. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Zahl PH; Gøtzsche PC; Mæhlen J Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169 [TBL] [Abstract][Full Text] [Related]
5. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project. Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530 [TBL] [Abstract][Full Text] [Related]
6. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. May DS; Lee NC; Nadel MR; Henson RM; Miller DS AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608 [TBL] [Abstract][Full Text] [Related]
7. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. Andersson I; Aspegren K; Janzon L; Landberg T; Lindholm K; Linell F; Ljungberg O; Ranstam J; Sigfússon B BMJ; 1988 Oct; 297(6654):943-8. PubMed ID: 3142562 [TBL] [Abstract][Full Text] [Related]
8. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Zackrisson S; Andersson I; Manjer J; Janzon L Int J Cancer; 2004 Feb; 108(5):754-60. PubMed ID: 14696103 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635 [TBL] [Abstract][Full Text] [Related]
10. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening? Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971 [TBL] [Abstract][Full Text] [Related]
11. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening. Weigel S; Batzler WU; Decker T; Hense HW; Heindel W Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859 [TBL] [Abstract][Full Text] [Related]
12. Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons. Frisell J; Glas U; Hellström L; Somell A Breast Cancer Res Treat; 1986; 8(1):45-54. PubMed ID: 3790749 [TBL] [Abstract][Full Text] [Related]
13. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg. Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511 [TBL] [Abstract][Full Text] [Related]
14. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331 [TBL] [Abstract][Full Text] [Related]
15. Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county. Fagerberg G; Baldetorp L; Gröntoft O; Lundström B; Månson JC; Nordenskjöld B Acta Radiol Oncol; 1985; 24(6):465-73. PubMed ID: 3006435 [TBL] [Abstract][Full Text] [Related]
16. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999. Zackrisson S; Janzon L; Manjer J; Andersson I J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086 [TBL] [Abstract][Full Text] [Related]
17. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. Jonsson H; Nyström L; Törnberg S; Lenner P J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer screening with mammography: a population-based, randomized trial with mammography as the only screening mode. Andersson I; Andrén L; Hildell J; Linell F; Ljungqvist U; Pettersson H Radiology; 1979 Aug; 132(2):273-6. PubMed ID: 461778 [TBL] [Abstract][Full Text] [Related]
19. Mammography in symptomatic and asymptomatic patients. Stomper PC; Gelman RS Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492 [TBL] [Abstract][Full Text] [Related]
20. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92. Otten JD; van Dijck JA; Peer PG; Straatman H; Verbeek AL; Mravunac M; Hendriks JH; Holland R J Epidemiol Community Health; 1996 Jun; 50(3):353-8. PubMed ID: 8935470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]